Caplacizumab shortage status
1 active shortage notice across 1 country.
Last updated 16 Sept 2026 · sourced from official medicines regulators
- Generic name (INN)
- Caplacizumab
- Brand names
- Cablivi
- Class
- Auto-created by INFARMED — Gestão da Disponibilidade do Medicamento scraper
Where Caplacizumab is in shortage
Why Caplacizumab is in shortage
- supply-chain disruption — e.g. “Export restricted due to shortage” (Portugal)
Frequently asked questions
Is Caplacizumab currently in shortage?
Yes. As of the latest regulator updates, Caplacizumab has 1 active shortage notice across 1 country (Portugal). Status is refreshed daily from official regulatory sources.
Why is Caplacizumab in shortage?
Regulators attribute the current Caplacizumab shortages to supply-chain disruption. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Caplacizumab shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Caplacizumab status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.